Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Mesenchymal Stem Cell in Patients With COVID-19 Associated SARS-CoV-2, Retrospective Clinical Study: When to Apply to Which Patient?

NCT05240430 is registered in ClinicalTrials.gov with Trabzon Kanuni Education and Research Hospital as lead sponsor.

NCT NCT05240430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05240430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Mesenchymal Stem Cell in Patients With COVID-19 Associated SARS-CoV-2, Retrospective Clinical Study: When to Apply to Which Patient?
Lead sponsor
Trabzon Kanuni Education and Research Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2022
Completion date
March 31, 2022
Enrollment
1 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 acute respiratory distress syndrome